2-((3-chloro-2-methylphenyl)(methyl)amino)-N-(4-hydroxybenzyl)benzamide

ID: ALA5198346

Chembl Id: CHEMBL5198346

PubChem CID: 168287727

Max Phase: Preclinical

Molecular Formula: C22H21ClN2O2

Molecular Weight: 380.88

Names and Identifiers

Canonical SMILES:  Cc1c(Cl)cccc1N(C)c1ccccc1C(=O)NCc1ccc(O)cc1

Standard InChI:  InChI=1S/C22H21ClN2O2/c1-15-19(23)7-5-9-20(15)25(2)21-8-4-3-6-18(21)22(27)24-14-16-10-12-17(26)13-11-16/h3-13,26H,14H2,1-2H3,(H,24,27)

Standard InChI Key:  KZGPPWLVWQEBLV-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5198346

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 380.88

Molecular Weight (Monoisotopic): 380.1292

AlogP: 5.05

#Rotatable Bonds: 5

Polar Surface Area: 52.57

Molecular Species: NEUTRAL

HBA: 3

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 4

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 9.49

CX Basic pKa: ┄

CX LogP: 5.25

CX LogD: 5.25

Aromatic Rings: 3

Heavy Atoms: 27

QED Weighted: 0.65

Np Likeness Score: -1.10

References

1. Li J, Hu X, Zhang H, Peng Y, Li S, Xiong Y, Jiang W, Wang Z..  (2022)  N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression.,  65  (15.0): [PMID:35868003] [10.1021/acs.jmedchem.2c00635]

Source

Source(1):

• Scientific Literature